Marion Wobser

22PUBLICATIONS
106CO-AUTHORS
AutoimmunityHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|May 22, 2026
Second-line treatment with tafasitamab and lenalidomide for relapsed/refractory primary cutaneous diffuse large B-cell lymphoma.

|Apr 23, 2026
DNA methylation-based classification of hematolymphoid neoplasms.

|Feb 11, 2026
Management of Mycosis Fungoides With Chlormethine Hydrochloride Gel in Combination With Systemic Therapies: A Case Series.

Gabor Dobos, Constanze Jonak, Kai-Christian Klespe

|Jan 10, 2026
Brentuximab Vedotin in Advanced-Stage Mycosis Fungoides/Sézary Syndrome with Low CD30 Expression: Real-World Data from the German Cutaneous Lymphoma Network.

Christoph Blazejak, Mathias Oymanns, René Stranzenbach

|Dec 23, 2025
Haematopoietic stem cell transplantation for cutaneous T-cell lymphomas: Decision-guiding prognostic determinants yet to be clarified.

Marion Wobser

|Sep 30, 2025
Brentuximab vedotin and radiotherapy for CD30-positive cutaneous T-cell lymphoma - a retrospective multicenter analysis.

Patrick Schummer, Caroline Glatzel, Philipp Schrüfer

Pageof 4

Frequent Collaborators

6 joint publications

Rudolf Stadler

6 joint publications

Matthias Goebeler

5 joint publications

Ulrike Wehkamp

5 joint publications

Emmanuella Guenova